STOCK TITAN

Hillenbrand Completes Sale of ABEL Pumps to IDEX Corporation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Hillenbrand has completed the sale of Abel Pumps to IDEX Corporation for approximately $103.5 million. This strategic divestiture aligns with Hillenbrand's goal to streamline its portfolio and enhance financial flexibility. The company plans to utilize the proceeds to reduce leverage and reinvest in organic growth opportunities. CEO Joe Raver emphasized this move as a vital step towards increasing shareholder value and strengthening business platforms.

Positive
  • Generated cash proceeds of approximately $103.5 million from the sale of Abel Pumps.
  • Strategic divestiture enhances financial flexibility and positions the company for future growth.
  • Focused on reducing leverage and reinvesting in organic growth opportunities, potentially increasing shareholder value.
Negative
  • None.

BATESVILLE, Ind., March 11, 2021 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) announced today that it has completed the sale of Abel Pumps, L.P., and certain of its affiliates (ABEL) to IDEX Corporation (NYSE: IEX). The sale closed in accordance with the terms of the Share and Interest Purchase and Transfer Agreement with IDEX that was announced on January 11, 2021, resulting in cash proceeds to Hillenbrand of approximately $103.5 million.

"The ABEL divestiture is an important step in our strategy to streamline our portfolio, increase financial flexibility, and accelerate growth," said Joe Raver, President and CEO of Hillenbrand. "The completion of the ABEL sale will help drive shareholder value and strengthen our key business platforms."

Consistent with its current capital allocation priorities, Hillenbrand intends to use proceeds from the sale to reduce leverage and reinvest in organic growth opportunities.

About Hillenbrand
Hillenbrand (www.hillenbrand.com) is a global diversified industrial company with businesses that serve a wide variety of industries around the world. We pursue profitable growth and robust cash generation to drive increased value for our shareholders. Hillenbrand's portfolio includes industrial businesses such as Coperion, Milacron Injection Molding & Extrusion, and Mold-Masters, in addition to Batesville, a recognized leader in the death care industry in North America. Hillenbrand is publicly traded on the NYSE under "HI."

Forward-Looking Statements

Throughout this release, we make a number of "forward-looking statements" that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and that are intended to be covered by the safe harbor provided under these sections. As the words imply, these are statements about future sales, earnings, cash flow, results of operations, uses of cash, financings, share repurchases, ability to meet deleveraging goals, and other measures of financial performance or potential future plans or events, strategies, objectives, beliefs, prospects, assumptions, expectations, and projected costs or savings or transactions of the Company that might or might not happen in the future, as contrasted with historical information. Forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand's (the "Company") expectations and projections.

Words that could indicate that we are making forward-looking statements include the following:

























intend

believe

plan

expect

may

goal

would

project

become

pursue

estimate

will

forecast

continue

could

anticipate

target

encourage

promise

improve

progress

potential

should

impact

This is not an exhaustive list, but is intended to give you an idea of how we try to identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking.

Here is the key pointForward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: the impact of contagious diseases such as the COVID-19 pandemic and the societal, governmental, and individual responses thereto, including supply chain disruptions, loss of contracts and/or customers, erosion of some customers' credit quality, downgrades of the Company's credit quality, closure or temporary interruption of the Company's or suppliers' manufacturing facilities, travel, shipping and logistical disruptions, loss of human capital or personnel, and general economic calamities; the outcome of any legal proceedings that may be instituted against the Company, or any companies we may acquire; risks that the integration of Milacron or any other integration, acquisition, or disposition activity disrupts current operations or poses potential difficulties in employee retention or otherwise affects financial or operating results; the ability to recognize the benefits of the acquisition of Milacron or any other acquisition or disposition, including potential synergies and cost savings or the failure of the Company or any acquired company to achieve its plans and objectives generally; global market and economic conditions, including those related to the credit markets; volatility of our investment portfolio; adverse foreign currency fluctuations; involvement in claims, lawsuits and governmental proceedings related to operations; our reliance upon employees, agents, and business partners to comply with laws in many countries and jurisdictions; labor disruptions; the impact of the additional indebtedness that the Company has incurred in connection with the acquisition of Milacron and the ability of the Company to comply with financial or other covenants in its debt agreements or meet its de-leveraging goals; the dependence of our business units on relationships with several large providers; increased costs or unavailability of raw materials or certain outsourced services; continued fluctuations in mortality rates and increased cremations; competition in the industries in which we operate, including from nontraditional sources in the death care industry; our level of international sales and operations; cyclical demand for industrial capital goods; impacts of decreases in demand or changes in technological advances, laws, or regulation on the revenues that we derive from the plastics industry; certain tax-related matters; and changes to legislation, regulation, treaties or government policy, including any resulting from the current political environment. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in Part I, Item 1A of Hillenbrand's Form 10-K for the year ended September 30, 2020, filed with the Securities and Exchange Commission ("SEC") on November 12, 2020, and in Part II, Item 1A of Hillenbrand's Form 10-Q for the quarter ended December 31, 2020, filed with the SEC on February 3, 2021. The forward-looking information in this presentation speaks only as of the date covered by these materials, and we assume no obligation to update or revise any forward-looking information.

 

Hillenbrand - a global diversified industrial company. (PRNewsfoto/Hillenbrand, Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hillenbrand-completes-sale-of-abel-pumps-to-idex-corporation-301245624.html

SOURCE Hillenbrand, Inc.

FAQ

What is the significance of Hillenbrand's sale of Abel Pumps to IDEX?

The sale allows Hillenbrand to streamline its portfolio, improve financial flexibility, and focus on growth initiatives.

How much did Hillenbrand receive from the sale of Abel Pumps?

Hillenbrand received approximately $103.5 million from the sale.

What will Hillenbrand do with the proceeds from the Abel sale?

Hillenbrand intends to use the proceeds to reduce leverage and reinvest in organic growth opportunities.

When was the sale of Abel Pumps announced?

The sale was announced on January 11, 2021.

What is the stock symbol for Hillenbrand?

Hillenbrand is publicly traded on the NYSE under the symbol 'HI'.

Who is the CEO of Hillenbrand?

Joe Raver is the President and CEO of Hillenbrand.

Hillenbrand, Inc.

NYSE:HI

HI Rankings

HI Latest News

HI Stock Data

2.07B
69.54M
0.87%
93.46%
3.33%
Specialty Industrial Machinery
Miscellaneous Manufacturing Industries
Link
United States of America
BATESVILLE